20.90 USD
↗ 0.24 (1.16%)AT CLOSE (11:59 AM EDT)
Innoviva, Inc. Common Stock
INVANASDAQ • USD
20.90
↘ 0.01 (0.02%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
20.90
↘ 0.01 (0.02%)
Market: CLOSED
Innoviva, Inc. Common Stock (INVA) is currently trading at $20.91. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, exceptional Return on Equity (29.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, INVA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 14, 2026.
Open?$20.93
High?$21.11
Low?$20.69
Prev. Close?$20.66
Volume?1.1M
Avg. Volume?680.0K
VWAP?$20.97
Rel. Volume?1.63x
Bid / Ask
Bid?$17.20 × 100
Ask?$24.40 × 100
Spread?$7.20
Midpoint?$20.80
Valuation & Ratios
Market Cap?1.5B
Shares Out?72.2M
Float?69.5M
Float %?94.1%
P/E Ratio?4.18
P/B Ratio?1.21
EPS?$4.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Address
1350 OLD BAYSHORE HIGHWAY
BURLINGAME, CA 94010
Phone: (650) 238-9600
BURLINGAME, CA 94010
Phone: (650) 238-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?79
Momentum?95
Short Sent.?48
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.29Safe
Confidence?61%Moderate
Short InterestVery High
Short % of Float?9.99%Elevated
Short Interest?6.9M
Days to Cover?11.8
Free Float69.5M
Avg Daily Volume588.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?16.01Strong
Quick Ratio?15.18Strong
Cash Ratio?12.12Strong
Debt/Equity?0.21Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score94/100
P/E?4.2CHEAP▾
Peers100
S&P97
P/B?1.21CHEAP▾
Peers100
S&P93
P/S?3.39FAIR▾
Peers100
S&P45
P/FCF?7.9CHEAP▾
Peers100
S&P93
EV/EBITDA?6.2CHEAP▾
Peers100
S&P97
EV/Sales?2.69CHEAP▾
Peers100
S&P65
Returns & Efficiency
ROE?29.0%STRONG▾
Peers50
S&P78
ROA?21.0%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$189.4M
Enterprise Value?$1.2B
Fundamentals ratios updated end of day